Verastem Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Verastem Stock Summary

Verastem competes with Viking Therapeutics, and Karyopharm Therapeutics. Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Verastem operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.

Verastem Key Financial Ratios

Verastem Key Balance Sheet Accounts

Verastem Key Income Statement Accounts

Verastem Key Cash Accounts

Verastem Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Verastem's current stock value. Our valuation model uses many indicators to compare Verastem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Verastem competition to find correlations between indicators driving Verastem's intrinsic value. More Info.Verastem is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Verastem's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Verastem by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Verastem Systematic Risk

Today, most investors in Verastem Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Verastem's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Verastem growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Verastem help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Verastem. We use our internally-developed statistical techniques to arrive at the intrinsic value of Verastem based on widely used predictive technical indicators. In general, we focus on analyzing Verastem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Verastem's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.